Research
Grapp-CAIB generates valid knowledge of the effectiveness and efficiency of innovative interventions in prevention and health promotion.
Mission
The mission of the Grapp-CAIB is to generate valid knowledge of the efficacy, effectiveness and efficiency of innovative interventions in prevention and health promotion and to transfer it to citizens and professionals, especially those in primary care, public health and health service managers.
The research conducted in cancer, cardiovascular risk factors, and other aspects of prevention and promotion is highly applied: the knowledge generated is transferred to public health or primary care clinics.
Main research lines
1. Determinants of health, healthy lifestyles and promotion of healthy habits.
Through this line of research we aim to study how interventions based on the promotion of healthy lifestyles can contribute to reversing, treating and preventing chronic diseases. This is a line in which a multidisciplinary group works that includes different health professionals and experts in areas such as nutrition, psychology and physical activity.
2. Health and patient safety services.
Health services research is a multidisciplinary scientific field that examines how the population gains access to health professionals and health care services, how much health services cost, and what happens to patients as a result of the provision of these services. Our group focuses specifically on the areas of healthcare quality, patient safety, patient-centered care, and the development and evaluation of digital health-based interventions for the prevention and management of chronic diseases.
3. Epidemiology for cardiovascular risk reduction.
Cardiovascular diseases remain the leading cause of death worldwide. Our research group carries out projects aimed at obtaining greater knowledge about the incidence and prevalence of cardiovascular risk factors, as well as the various forms of cardiovascular disease in different countries and regions.
4. Cancer: epidemiology, prevention and treatment.
Through this line of research we study how primary care services aimed at cancer prevention, as well as its treatment, surveillance and palliative care, can be improved.
5. Clinical research in primary care.
The clinical research carried out by our group in the field of primary care aims to generate new knowledge that helps in the diagnosis, treatment and prevention of diseases in humans.
6. Nursing care.
The objective of this line is to develop and promote nursing actions for the promotion and coordination of multidisciplinary and translational research in care, fostering the link between practice and research, and enabling the implementation of safe and high-quality care that improves patient health. This line is part of the Spanish Center for Evidence-Based Health Care (CECBE), which is part of the Joanna Briggs International Collaboration of the research unit Investén-isciii of the Carlos III Health Institute.
7. Childhood and environment.
The objective of this line of research is to study the role of the most important environmental pollutants in air, water, and diet during pregnancy and early life, and their effects on child growth and development.


Projects
Projects led by GRAPP-caIB in the last 3 years.
Promoting the transfer of DiabeText, a digital tool integrated with the clinical history to improve the health and quality of life of people with diabetes
PI: Ignacio Ricci Cabello
Funding: 149,500
Duration: 2023-2024
Contract/project file: PDC2022-133257-I00
Collaborating researchers: Claudio Mirasso Santos, Aina Yáñez Juan, Miquel Bennasar Veny, Esperança Amengual Alcover, Jordi Llabrés Bordoy, Elena Gervilla García, Silvia Ortín González, Escarlata Angullo Martínez, Carlos Enrique Herrero, María Asunción Boronat Moreiro, Sofía Mira Martínez, María Zaforteza Dezcallar, María Jesús Serrano Ripoll, María Antònia Fiol de Roque, Rocío Zamanillo Campos.
Methodological Support for the Performance of Literature Reviews within Evidence-based Scientific Assessments. PI Baleares: Ignacio Ricci Cabello
Funding: 4,000,000€
Duration: 2022-2026
Contract/project file: OC/EFSA/MESE/2022/03
Collaborating researchers: María Adoración Romaguera, Miquel Bennasar Veny
Multimorbilidad en el Sistema Nacional de Salud: Caracterización poblacional e impacto de sus patrones y trayectorias en personas mayores (Proyecto MM-SNS) IP: Angélica Miguélez Chamorro Financiación: 33.880,00 € Duración: 2023-2025 Expediente contrato/proyecto: PI22/01684 Investigadores colaboradores: Bernardino Oliva Fanlo, Patricia Lorente Montalvo, Miguel Bennasar Veny, Joan Llobera Cànaves, Aina Maria Yañez Juan, Maria Antònia Fiol de Roque, Estefania Serratusell Sabater
Audit & Feedback Intervention to Reduce Inappropriate Medication Prescription in Patients Aged 65 and Over in Primary Care. AIM Study: Multicenter Clinical Trial. PI: Alfonso Leiva Rus
Funding: 75,020.00 €
Duration: 2023-2025
Contract/project file: PI22/01669
Collaborating researchers: Catalina Vicens Caldentey, Aina Maria Yañez Juan, Mónica Martínez Cengotitabengoa, Ermengol Sempere Verdú, Marta Llarena Fernández, Rita Sainz de Rozas Aparicio, Itxasne Lekue Alkorta, Alba Gallego Royo, Isabel Maria Socias Buades, Agustín González Vicens, Francesc Company Bezares, Maria Lluisa Sastre Martorell, Sebastián Jaume Gayà, Cruz Belén Bartolomé Moreno, Ferrán Bejarano Romero
Audit & Feedback Intervention to Reduce Antibiotic Prescription in Primary Care (AFA Study).
PI: Laura Gallardo Alfaro (PI), Aina Soler Mieras (Co-PI)
Funding Agency: Research Projects in Health. Carlos III Health Institute
Funding: 38,720.00 €
Duration: 2023-2025
Contract/project file: PI22/01742
Collaborating researchers: Rafael Torres García, Antònia Roca Casas, Isabel Maria Socias Buades, Kaoutar Ziani Akrirout, Sofía Mira Martínez, Francesc Company Bezares.
Evaluation of SINERGIAPS, an intervention aimed at improving patient safety in healthcare centers in Spain based on the perceptions and experiences of the patients themselves.
PI: Ignacio Ricci Cabello
Funding Agency: Research Projects in Health. Carlos III Health Institute
Funding: 119,790.00 €
Duration: 2023-2025
Contract/project file: PI22/01521
Collaborating researchers: José María Valderas, Antonio Olry de Labry Lima, Maria Antonia Fiol de Roque, Sara Guerrero, María Costa Marín, Clara González Formoso, Fernando Isidro Lago, Sofía Mira Martínez
IMPaCT Cohort. Predictive Medicine Program. Precision Medicine Infrastructure associated with Science and Technology (IMPaCT).
PI Baleares: Joan Llobera Cànaves (PI), Xènia Chela Álvarez (technical coordinator)
Funding Agency: Carlos III Health Institute
Funding: 233,909.94 €
Duration: 2021-2024
Contract/project file: IMP/00021
Collaborating researchers Baleares: Antònia Salvà Fiol, Noemí Pérez García, Eugenia Carandell Jäger, Antònia Roca Casas, Joana Maria Taltavull Aparicio, Oana Bulilete, Joana Ripoll Amengual, Jerònia Miralles Xamena, Caterina Vicens Caldentey
Public Health and Precision Preventive Medicine combining physical examination, lifestyle habits, and genomic information: monitoring the obesity pandemic through the extension of the IMPaCT Cohort (Obes-IMPaCT).
Funding Agency: Carlos III Health Institute
Duration: 2024-2026
Contract/project file: PMP22/00003
Collaborating researchers Baleares: Joan Llobera Cànaves, José Ignacio Ramírez Manent, Catalina Villalonga Munar
Validation of lung ultrasound, performed by family doctors, as an initial imaging test to diagnose pneumonia in COVID-19 patients.
PI: José Ignacio Ramírez Manent
Funding agency: Health research projects. Carlos III Health Institute.
Funding: 37,510€
Duration: 2022-2024
Contract/project file: PI21/01521
Collaborating researchers: Antonia Roca Casas, Ignacio Ramírez Manent, Magdalena Esteva Cantó, Miguel Román Rodríguez, José Corcoll Reixach, Antonio Albaladejo Dávalos, Cristina Gadea Ruíz, Álvaro Moran Bayón.
How can potentially inappropriate prescriptions in Primary Care be effectively reduced? Exploratory study for the design of an evidence-based intervention.
PI: María Antònia Fiol de Roque
Funding agency: Illes Balears Health Research Institute (IdISBa). IMPETUS 2021 intramural call.
Funding: 10,000€
Duration: 2022-2023
Contract/project file: IMP21/02
Collaborating researchers: Ignacio Ricci Cabello, Aina Soler Mieras, Maria Jesús Serrano-Ripoll, David Medina Bombardó, Elena Gervilla.
Clinical effectiveness and bacteriological eradication of 4 short antibiotic regimens in lower urinary tract infections in adult women (SCOUT Study).
PI: Alfonso Leiva Rus
Funding agency: Health research projects. Carlos III Health Institute.
Funding: 82,500€
Duration: 2 years (January 2021 – December 2022)
Contract/project file: ICI20/00128
Collaborating researchers: Antonia Roca Casas, José Ignacio Ramírez Manent , Joan Llobera Canaves, Antonio Ballester Camps, Catalina Vicens Caldentey, Aina MariaYañez Juan, Ignacio Ricci Cabello, Aina Soler Mieras, Eva Alcoceba Cruixent, Maria Consuelo Corrionero Soto, Joana Ripoll Amengual
Development and evaluation of the effectiveness, cost-effectiveness, and implementation of a low-intensity, multicomponent digital intervention to prevent type 2 diabetes mellitus within primary care: PREDIABETEXT study.
PI:Ignacio Ricci Cabello (IP), Escarlata Angullo Martínez (Co-PI)
Funding agency: Illes Balears Health Research Institute (IdISBa) – Sinergias 2020 intramural call
Funding: 20,000€
Duration: 2 years (January 2021 – December 2022)
Contract/project file: SYN20/04
Collaborating researchers: Maria Jesús Serrano Ripoll, Maria Antonia Fiol de Roque, Joan Llobera Canaves, Alfonso Leiva Rus, Oana, BulileteBulilete, JadwigaKonieczna, Elena Gervilla, Miquel Roca Bennasar, Margalida Gili Planas, Mauro García-Toro, Miquel Bennasar Veny, Aina MariaYañez Juan, Aina Galmés Panadés, Maria Adoración Romaguera Bosch, Rafa Jiménez López, Catalina Vicens Caldentey, Rocío Gómez Juanes, Clara Vidal Thomás, Juan José Montaño Moreno
Project for the evaluation and update of indicators for the main comorbidities and complications of type 2 diabetes mellitus: the case of heart failure.
PI: Ignacio Ricci Cabello (IP), Rocío Zamanillo Campos (Co-PI)
Funding agency: Astrazeneca
Funding: 20,000€
Duration: 1 year (January 2021 – December 2021)
Contract/project file: PSID/INDICA
Effectiveness and cost-utility of cognitive-behavioral intervention in primary care nurses’ and doctors’ consultations for the treatment of persistent insomnia.
PI: Susana González, Isabel Torrens (coPIs)
Funding agency: Health research projects. Carlos III Health Institute.
Funding: 26,620€
Duration: 2019 – 2021
Contract/project file: PI19/00029
Collaborating researchers: Jerónima Miralles, Clara Vidal, Rosa Pizá, Apol•lonia Esteva, Marta Pisà, Patricia Lorente, Catalina Vicens
Cohorte DESVELA. Análisis del papel de las aptitudes personales como determinantes de la incidencia de morbilidad, estilos de vida, calidad de vida, uso de servicios y mortalidad.
PI: Joan Llobera
Funding agency: Health research projects. Carlos III Health Institute.
Funding: 27,890.50€
Duration: 2019-2022
Contract/project file: PI19/01868
Collaborating researchers: David Medina, Jose María Coll, Matías Torrent, Catalina Vicens, Joana Ripoll, Clara Vidal, Oana Bulilete.
Development, evaluation, and large-scale implementation of PSICOVIDAPP, a psychoeducational intervention through a mobile application to mitigate mental health issues in healthcare professionals responding to the COVID-19 pandemic.
PI: Mauro García Toro (PI), Ignacio Ricci Cabello (Co-PI)
Funding Agency: 2020 Spanish Foundation of Psychiatry and Mental Health Grants.
Funding: 41,000€
Duration: 14 months (October 2020 – December 2021)
Contract/project file: SEP20/01
Collaborating researchers: Miquel Bennasar Veny, Maria Antonia Fiol de Roque, Elena Gervilla García, Rafael Jiménez López, Alfonso Leiva Rus, Joan Llobera Canaves, Joan Salvà Coll, Maria Jesús Serrano Ripoll, Rocío Zamanillo Campos, Aina Maria Yáñez Juan, Carolina Sitges, Javier García Campayo, Maria Esther García Buades, Guadalupe Pastor Moreno, Isabel Ruíz Pérez, Pablo Alonso Coello
Retrospective cohort study to assess the prognostic impact of exposure to COVID-19 risk drugs.
PI:Aina Soler Mieras
Funding agency: Illes Balears Health Research Institute (IdISBa) – Extraordinary call for expressions of interest for research projects in response to the COVID-19 pandemic.
Funding: 9,600€
Duration: 2020 – 2021
Contract/project file: COVID-19/26
Collaborating researchers: Amaia Alcorta Lorenzo, Ana Aretio, Gemma Arrufat, Guillem Marc Campins Adrover, Francesc Company Bezares, Barbara Ferrer Jaillard, Angel García Álvarez, Aurelia Iglesias Iglesias, Olatz Pérez Rodríguez, Francisca Ramis Riera, Marta Rovira Vila, Mª Luisa Sastre Martorell, Raquel Seco Melantuche, Ana Vanrell Ballestero, Magdalena Esteva Cantó.
Evolution of seroprevalence against SARS-CoV-2 in the healthy adult population of the Balearic Islands.
PI: Joan Llobera Canaves and Antonio Gayà Oliver.
Funding agency: Illes Balears Health Research Institute (IdISBa) – Extraordinary call for expressions of interest for research projects in response to the COVID-19 pandemic.
Funding: 42,680€
Duration: 2020 – 2021
Contract/project file: COVID-19/10
Collaborating researchers: Oana Bulilete, Javier Calvo Benito, Enrique Girona Llobera, Alfonso Leiva Rus, Antonio Oliver Palomo, Maties Torrent Quetglas.
Effectiveness of an intervention based on the use of mobile technology for the prevention of mental health issues in healthcare professionals on the frontlines of patient care for COVID-19.
PI: Ignacio Ricci Cabello and Maria Jesús Serrano Ripoll
Funding agency: Illes Balears Health Research Institute (IdISBa) – Extraordinary call for expressions of interest for research projects in response to the COVID-19 pandemic.
Funding: 48,500€
Duration: 18 months (2020 May – 2021 November)
Contract/project file: COVID-19/06
Collaborating researchers: Miquel Bennasar Veny, Maria Antonia Fiol de Roque, Mauro García Toro, Elena Gervilla García, Rafael Jiménez López, Alfonso Leiva Rus, Joan Llobera Canaves, Joan Salvà Coll, Maria Jesús Serrano Ripoll, Rocío Zamanillo Campos, Aina Maria Yáñez Juan, Carolina Sitges, Javier García Campayo, Maria Esther García Buades, Guadalupe Pastor Moreno, Isabel Ruíz Pérez, Pablo Alonso Coello
Impact of COVID-19 lockdown on lifestyle and emotional well-being of the adult population in the Balearic Islands (COVID-19/23) Research projects on SARS-CoV-2 and COVID-19. GOIB-IdISBa. Principal investigator: Joana Ripoll Amengual. Duration: 2020 – 2021.
Promoting adherence to antidiabetic medication in patients with type 2 diabetes through a mobile technology system integrated with computerized medical records (RTI2018-096935-A-I00) R+D+i Projects “Retos investigación”. Ministry of Science, Innovation and Universities. Principal Investigator: Ignacio Ricci Cabello. Duration: 2019 – 2022.
Prevention of depression in the workplace through a personalized intervention based on risk algorithms, ICT, and decision support systems: randomized controlled trial (PI18/01306)
Health research projects. Carlos III Health Institute. Principal investigator: Alfonso Leiva Rus. Duration: 2019 – 2021.
Cancer diagnosis in primary care: the value of the family doctor’s intuition GUT FEELINGS (PI18/01462) Health research projects. Carlos III Health Institute. Principal investigators: Magdalena Esteva Cantó and Bernardino Oliva Fanlo. Duration: 2019 – 2021.
Information and research needs in breast cancer from the perspective of patients and professionals. V Edition Scholarship of the Fundación DISA Biomedical Research Awards 2019. Principal investigator: Beatriz León Salas (FISSC). Co-principal investigator: Magdalena Esteva Cantó. Duration: 2019 – 2020.
Design of an intervention for the prevention of depression in patients with subclinical symptoms through the promotion of healthy lifestyles using a smartphone application (App): a formative study (PI005_20) VII Research Projects Grants AP Mallorca 2020. GAP Mallorca. Principal investigator: Mª Jesús Serrano Ripoll. Duration: 2020 – 2021.
Project for the evaluation and update of indicators for the main comorbidities and complications of type 2 diabetes mellitus: the case of heart failure (PSID/INDICA) AstraZeneca. Principal investigator: Ignacio Ricci Cabello. Duration: 2020 – 2021.
Translation into Catalan and psychometric validation of the questionnaire “Patient Reported Experiences and Outcomes of Safety in Primary Care” PREOS-PC (INAP/SERRANO) VI Research Projects Grants AP Mallorca 2019. GAP Mallorca. Principal investigator: Mª Jesús Serrano Ripoll. Duration: 2019 – 2020.
Evaluation of the implementation of clinical ultrasound in the Primary Care area of Mallorca (INAP/BULILETE) VI Research Projects Grants AP Mallorca 2019. GAP Mallorca. Principal investigator: Oana Bulilete. Duration: 2019 – 2020.
Effectiveness of medication self-management, self-monitoring of blood pressure, diet, and physical exercise in reducing blood pressure in difficult-to-control patients (AMADEF) (PI17/02108) Health research projects. Carlos III Health Institute. Principal investigators: Fabián Unda Villafuerte and Fernando Rigo Carratalà. Duration: 2018 – 2022.
Development and Evaluation of an Intervention based on the Provision of Patient Feedback to Improve Patient Safety in Spanish Primary Care Centres (CP17/00017) Miguel Servet Type I Contract. Carlos III Health Institute. Principal investigator: Ignacio Ricci Cabello. Duration: 2018 – 2021.
Housekeeping staff and health (ITS 17-096) II Call for grants from the sustainable tourism tax. GOIB. Principal investigator: Joan Llobera Cànaves. Duration: 2018 – 2021.
Effectiveness of the Otago exercise program applied in a group versus individual format on the likelihood of falls in non-institutionalized individuals aged 65-80 years (PI16/01316) Health research projects. Carlos III Health Institute. Principal investigator: Jerónima Miralles Xamena. Duration: 2017 – 2021.
Pragmatic, open-label, evaluator-blinded, randomized clinical trial to assess the efficacy of maintaining pharmacological treatment in patients with advanced dementia (PI16/00720) Health research projects. Carlos III Health Institute. Principal investigator: Aina Soler Mieras. Duration: 2017 – 2021.
Effectiveness of the use of information and communication technologies in increasing physical activity and weight loss in obese and sedentary individuals. RCT. EVIDENT III Study (PI16/00421). Health research projects. Carlos III Health Institute. Principal investigator: José Ignacio Ramírez Manent. Duration: 2017 – 2021.
Research on the socio-health effects of COVID-19 among the migrant population: the example of Son Gotleu (Palma). II Call for research on social impact applied to sustainable human development in the context of COVID-19. Office of Development Cooperation and Solidarity, UIB. Principal investigator: Mª de Lluc Bauzà Amengual. Duration: 2021.
Scientific publications

2025
AbstractURLBibTeXEndNoteDOIBibSonomy1.Mira-Martínez S, Malih N, Angullo-Martínez E, Zamanillo-Campos R, Yañez AM, Bennasar-Veny M, Gómez-Juanes R, Konieczna J, Jiménez R, Serrano-Ripoll MJ, Fiol deRoque MA, Leiva A, Galmes-Panades AM, Miralles-Xamena J, Vidal-Thomàs MC, Gómez-Cobo C, Gervilla E, Oña-Gil JI, Ricci-Cabello I. A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial. Journal of medical Internet research [Internet]. Canada; 2025 Oct.;27:e70981-e70981. https://pubmed.ncbi.nlm.nih.gov/41067715BACKGROUND: The diabetes epidemic continues to surge worldwide, demanding urgent and innovative solutions. Digital health interventions, particularly those targeting behavior change, hold promise due to their affordability and scalability. However, research in this field remains in its early stages. OBJECTIVE: This study aimed to evaluate the effectiveness of PREDIABETEXT (Prediabetes Text Message Digital Intervention for the Prevention of Type 2 Diabetes Mellitus), a digital health intervention, in reducing glycated hemoglobin (HbA(1c)) and in improving secondary clinical, physiological, and behavioral outcomes. METHODS: We conducted a 6-month, 3-arm, pragmatic cluster randomized clinical trial. We recruited patients with prediabetes (HbA(1c) levels between 6% and 6.4% in the previous 3 months or 2 consecutive fasting plasma glucose measurements of 110-125 mg/dL) registered at primary care centers in the Balearic Islands, Spain. The PREDIABETEXT intervention consisted of 3 personalized SMS text messages per week aimed at supporting lifestyle behavior changes and online training for their primary health care professionals. A total of 58 professionals (clusters) from 16 centers participated in the study and were randomized (1:1:1) to intervention group A (patient SMS text messaging), intervention group B (patient SMS text messaging+health care professional web-based training), or the control group (usual care). Following the 6-month intervention period, we conducted individual qualitative interviews with 8 patients and 7 health care professionals to evaluate their experiences with the intervention in terms of utility, satisfaction, and implementation barriers. RESULTS: In total, 58 health care professionals (clusters) were included, allocated to the control group (n=20, 34%; 119/365, 32.6% patients), intervention group A (SMS text messaging only; n=18, 31%; 106/365, 29% patients), and intervention group B (SMS text messaging+training; n=20, 34%; 140/365, 38.4% patients). The mean age of the patients was 59.79 (SD 9.75) years, and 54.5% (199/365) were female. The results of the intention-to-treat analysis at the 6-month time point showed that intervention A led to a small, nonsignificant reduction in HbA(1c) levels compared to the control group (β=-0.05, 95% CI -0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=-0.04, 95% CI -0.12 to 0.10; P=.56). No substantial differences were observed in the remaining secondary outcomes. Interviews revealed positive feedback from patients, who appreciated the intervention's dietary messages and their frequency and practicality. Participants suggested enhancements such as increased personalization, links to recipes, and nursing follow-ups. Health care professionals valued the online training but highlighted time constraints, suggesting shorter or blended formats to improve accessibility. CONCLUSIONS: While PREDIABETEXT did not significantly improve HbA(1c) levels, it demonstrated potential benefits for patient engagement. Further studies involving more intensive interventions are warranted to confirm the clinical impact on diabetes prevention. TRIAL REGISTRATION: ClinicalTrials.gov NCT05110625; https://www.clinicaltrials.gov/study/NCT05110625. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.3390/ijerph192214706.@article{miramartinez2025multifaceted,
abstract = {BACKGROUND: The diabetes epidemic continues to surge worldwide, demanding urgent and innovative solutions. Digital health interventions, particularly those targeting behavior change, hold promise due to their affordability and scalability. However, research in this field remains in its early stages. OBJECTIVE: This study aimed to evaluate the effectiveness of PREDIABETEXT (Prediabetes Text Message Digital Intervention for the Prevention of Type 2 Diabetes Mellitus), a digital health intervention, in reducing glycated hemoglobin (HbA(1c)) and in improving secondary clinical, physiological, and behavioral outcomes. METHODS: We conducted a 6-month, 3-arm, pragmatic cluster randomized clinical trial. We recruited patients with prediabetes (HbA(1c) levels between 6% and 6.4% in the previous 3 months or 2 consecutive fasting plasma glucose measurements of 110-125 mg/dL) registered at primary care centers in the Balearic Islands, Spain. The PREDIABETEXT intervention consisted of 3 personalized SMS text messages per week aimed at supporting lifestyle behavior changes and online training for their primary health care professionals. A total of 58 professionals (clusters) from 16 centers participated in the study and were randomized (1:1:1) to intervention group A (patient SMS text messaging), intervention group B (patient SMS text messaging+health care professional web-based training), or the control group (usual care). Following the 6-month intervention period, we conducted individual qualitative interviews with 8 patients and 7 health care professionals to evaluate their experiences with the intervention in terms of utility, satisfaction, and implementation barriers. RESULTS: In total, 58 health care professionals (clusters) were included, allocated to the control group (n=20, 34%; 119/365, 32.6% patients), intervention group A (SMS text messaging only; n=18, 31%; 106/365, 29% patients), and intervention group B (SMS text messaging+training; n=20, 34%; 140/365, 38.4% patients). The mean age of the patients was 59.79 (SD 9.75) years, and 54.5% (199/365) were female. The results of the intention-to-treat analysis at the 6-month time point showed that intervention A led to a small, nonsignificant reduction in HbA(1c) levels compared to the control group (β=-0.05, 95% CI -0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=-0.04, 95% CI -0.12 to 0.10; P=.56). No substantial differences were observed in the remaining secondary outcomes. Interviews revealed positive feedback from patients, who appreciated the intervention's dietary messages and their frequency and practicality. Participants suggested enhancements such as increased personalization, links to recipes, and nursing follow-ups. Health care professionals valued the online training but highlighted time constraints, suggesting shorter or blended formats to improve accessibility. CONCLUSIONS: While PREDIABETEXT did not significantly improve HbA(1c) levels, it demonstrated potential benefits for patient engagement. Further studies involving more intensive interventions are warranted to confirm the clinical impact on diabetes prevention. TRIAL REGISTRATION: ClinicalTrials.gov NCT05110625; https://www.clinicaltrials.gov/study/NCT05110625. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.3390/ijerph192214706.},
address = {Canada},
author = {Mira-Martínez, Sofía and Malih, Narges and Angullo-Martínez, Escarlata and Zamanillo-Campos, Rocío and Yañez, Aina M and Bennasar-Veny, Miquel and Gómez-Juanes, Rocío and Konieczna, Jadwiga and Jiménez, Rafael and Serrano-Ripoll, Maria J and Fiol deRoque, Maria Antonia and Leiva, Alfonso and Galmes-Panades, Aina M and Miralles-Xamena, Jerónima and Vidal-Thomàs, Maria Clara and Gómez-Cobo, Cristina and Gervilla, Elena and Oña-Gil, José Iván and Ricci-Cabello, Ignacio},
journal = {Journal of medical Internet research},
keywords = {evisap},
month = {oct},
pages = {e70981--e70981},
title = {A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial},
volume = 27,
year = 2025
}%0 Journal Article
%1 miramartinez2025multifaceted
%A Mira-Martínez, Sofía
%A Malih, Narges
%A Angullo-Martínez, Escarlata
%A Zamanillo-Campos, Rocío
%A Yañez, Aina M
%A Bennasar-Veny, Miquel
%A Gómez-Juanes, Rocío
%A Konieczna, Jadwiga
%A Jiménez, Rafael
%A Serrano-Ripoll, Maria J
%A Fiol deRoque, Maria Antonia
%A Leiva, Alfonso
%A Galmes-Panades, Aina M
%A Miralles-Xamena, Jerónima
%A Vidal-Thomàs, Maria Clara
%A Gómez-Cobo, Cristina
%A Gervilla, Elena
%A Oña-Gil, José Iván
%A Ricci-Cabello, Ignacio
%C Canada
%D 2025
%J Journal of medical Internet research
%P e70981--e70981
%R 10.2196/70981
%T A Multifaceted Digital Intervention for the Prevention of Type 2 Diabetes Mellitus in Primary Care (PREDIABETEXT): Cluster Randomized Trial
%U https://pubmed.ncbi.nlm.nih.gov/41067715
%V 27
%X BACKGROUND: The diabetes epidemic continues to surge worldwide, demanding urgent and innovative solutions. Digital health interventions, particularly those targeting behavior change, hold promise due to their affordability and scalability. However, research in this field remains in its early stages. OBJECTIVE: This study aimed to evaluate the effectiveness of PREDIABETEXT (Prediabetes Text Message Digital Intervention for the Prevention of Type 2 Diabetes Mellitus), a digital health intervention, in reducing glycated hemoglobin (HbA(1c)) and in improving secondary clinical, physiological, and behavioral outcomes. METHODS: We conducted a 6-month, 3-arm, pragmatic cluster randomized clinical trial. We recruited patients with prediabetes (HbA(1c) levels between 6% and 6.4% in the previous 3 months or 2 consecutive fasting plasma glucose measurements of 110-125 mg/dL) registered at primary care centers in the Balearic Islands, Spain. The PREDIABETEXT intervention consisted of 3 personalized SMS text messages per week aimed at supporting lifestyle behavior changes and online training for their primary health care professionals. A total of 58 professionals (clusters) from 16 centers participated in the study and were randomized (1:1:1) to intervention group A (patient SMS text messaging), intervention group B (patient SMS text messaging+health care professional web-based training), or the control group (usual care). Following the 6-month intervention period, we conducted individual qualitative interviews with 8 patients and 7 health care professionals to evaluate their experiences with the intervention in terms of utility, satisfaction, and implementation barriers. RESULTS: In total, 58 health care professionals (clusters) were included, allocated to the control group (n=20, 34%; 119/365, 32.6% patients), intervention group A (SMS text messaging only; n=18, 31%; 106/365, 29% patients), and intervention group B (SMS text messaging+training; n=20, 34%; 140/365, 38.4% patients). The mean age of the patients was 59.79 (SD 9.75) years, and 54.5% (199/365) were female. The results of the intention-to-treat analysis at the 6-month time point showed that intervention A led to a small, nonsignificant reduction in HbA(1c) levels compared to the control group (β=-0.05, 95% CI -0.21 to 0.10; P=.50), whereas intervention B showed a similar nonsignificant reduction (β=-0.04, 95% CI -0.12 to 0.10; P=.56). No substantial differences were observed in the remaining secondary outcomes. Interviews revealed positive feedback from patients, who appreciated the intervention's dietary messages and their frequency and practicality. Participants suggested enhancements such as increased personalization, links to recipes, and nursing follow-ups. Health care professionals valued the online training but highlighted time constraints, suggesting shorter or blended formats to improve accessibility. CONCLUSIONS: While PREDIABETEXT did not significantly improve HbA(1c) levels, it demonstrated potential benefits for patient engagement. Further studies involving more intensive interventions are warranted to confirm the clinical impact on diabetes prevention. TRIAL REGISTRATION: ClinicalTrials.gov NCT05110625; https://www.clinicaltrials.gov/study/NCT05110625. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.3390/ijerph192214706.
AbstractURLBibTeXEndNoteDOIBibSonomy1.Bescos R, Gallardo-Alfaro L, Ashor A, Rizzolo-Brime L, Siervo M, Casas-Agustench P. Nitrate and nitrite bioavailability in plasma and saliva: Their association with blood pressure - A systematic review and meta-analysis. Free radical biology & medicine [Internet]. United States; 2025 Jan.;226:70-83. https://pubmed.ncbi.nlm.nih.gov/39522567In this study, we conducted a systematic review and meta-analysis to determine plasma and salivary nitrate (NO(3)(-)) and nitrite (NO(2)(-)) concentrations under resting and fasting conditions in different type of individuals and their association with blood pressure levels. A total of 77 studies, involving 1918 individuals aged 19-74 years (males = 906; females = 1012), which measured plasma and/or salivary NO(3)(-) and NO(2)(-) using the chemiluminescence technique, were included. Mean plasma NO(3)(-) and NO(2)(-) concentrations were 33.9 μmol/L and 158.3 nmol/L, respectively. Subgroup analyses revealed lower plasma NO(3)(-) and NO(2)(-) concentrations in individuals with cardiometabolic risk (NO(3)(-): 21.2 μmol/L; 95 % CI, 13.4-29.0; NO(2)(-): 122.8 nmol/L; 95 % CI, 75.3-138.9) compared to healthy (NO(3)(-): 33.9 μmol/L; 95 % CI, 29.9-37.9; NO(2)(-): 159.5 nmol/L; 95 % CI, 131.8-187.1; P < 0.01) and trained individuals (NO(3)(-): 43.0 μmol/L; 95 % CI, 13.2-72.9; NO(2)(-): 199.3 nmol/L; 95 % CI, 117.6-281; P < 0.01). Mean salivary NO(3)(-) and NO(2)(-) concentrations were 546.2 μmol/L and 197.8 μmol/L, respectively. Salivary NO(3)(-), but no NO(2)(-), concentrations were higher in individuals with cardiometabolic risk (680.0 μmol/L; 95 % CI, 510.2-849.8; P = 0.001) compared to healthy individuals (535.9 μmol/L; 95 % CI, 384.2-687.6). A significant positive association (coefficient, 15.4 [95 % CI, 0.255 to 30.5], P = 0.046) was observed between salivary NO(3)(-) and diastolic blood pressure (DBP). These findings suggest that the health status is positively associated with plasma NO(3)(-) and NO(2)(-) concentrations, but the circulatory levels of these anions are not associated with blood pressure. Only salivary NO(3)(-) showed a significant positive association with DBP.@article{bescos2025nitrate,
abstract = {In this study, we conducted a systematic review and meta-analysis to determine plasma and salivary nitrate (NO(3)(-)) and nitrite (NO(2)(-)) concentrations under resting and fasting conditions in different type of individuals and their association with blood pressure levels. A total of 77 studies, involving 1918 individuals aged 19-74 years (males = 906; females = 1012), which measured plasma and/or salivary NO(3)(-) and NO(2)(-) using the chemiluminescence technique, were included. Mean plasma NO(3)(-) and NO(2)(-) concentrations were 33.9 μmol/L and 158.3 nmol/L, respectively. Subgroup analyses revealed lower plasma NO(3)(-) and NO(2)(-) concentrations in individuals with cardiometabolic risk (NO(3)(-): 21.2 μmol/L; 95 % CI, 13.4-29.0; NO(2)(-): 122.8 nmol/L; 95 % CI, 75.3-138.9) compared to healthy (NO(3)(-): 33.9 μmol/L; 95 % CI, 29.9-37.9; NO(2)(-): 159.5 nmol/L; 95 % CI, 131.8-187.1; P < 0.01) and trained individuals (NO(3)(-): 43.0 μmol/L; 95 % CI, 13.2-72.9; NO(2)(-): 199.3 nmol/L; 95 % CI, 117.6-281; P < 0.01). Mean salivary NO(3)(-) and NO(2)(-) concentrations were 546.2 μmol/L and 197.8 μmol/L, respectively. Salivary NO(3)(-), but no NO(2)(-), concentrations were higher in individuals with cardiometabolic risk (680.0 μmol/L; 95 % CI, 510.2-849.8; P = 0.001) compared to healthy individuals (535.9 μmol/L; 95 % CI, 384.2-687.6). A significant positive association (coefficient, 15.4 [95 % CI, 0.255 to 30.5], P = 0.046) was observed between salivary NO(3)(-) and diastolic blood pressure (DBP). These findings suggest that the health status is positively associated with plasma NO(3)(-) and NO(2)(-) concentrations, but the circulatory levels of these anions are not associated with blood pressure. Only salivary NO(3)(-) showed a significant positive association with DBP.},
address = {United States},
author = {Bescos, Raul and Gallardo-Alfaro, Laura and Ashor, Ammar and Rizzolo-Brime, Lucia and Siervo, Mario and Casas-Agustench, Patricia},
journal = {Free radical biology & medicine},
keywords = {grapp-caib},
month = {jan},
pages = {70--83},
title = {Nitrate and nitrite bioavailability in plasma and saliva: Their association with blood pressure - A systematic review and meta-analysis},
volume = 226,
year = 2025
}%0 Journal Article
%1 bescos2025nitrate
%A Bescos, Raul
%A Gallardo-Alfaro, Laura
%A Ashor, Ammar
%A Rizzolo-Brime, Lucia
%A Siervo, Mario
%A Casas-Agustench, Patricia
%C United States
%D 2025
%J Free radical biology & medicine
%P 70--83
%R 10.1016/j.freeradbiomed.2024.11.010
%T Nitrate and nitrite bioavailability in plasma and saliva: Their association with blood pressure - A systematic review and meta-analysis
%U https://pubmed.ncbi.nlm.nih.gov/39522567
%V 226
%X In this study, we conducted a systematic review and meta-analysis to determine plasma and salivary nitrate (NO(3)(-)) and nitrite (NO(2)(-)) concentrations under resting and fasting conditions in different type of individuals and their association with blood pressure levels. A total of 77 studies, involving 1918 individuals aged 19-74 years (males = 906; females = 1012), which measured plasma and/or salivary NO(3)(-) and NO(2)(-) using the chemiluminescence technique, were included. Mean plasma NO(3)(-) and NO(2)(-) concentrations were 33.9 μmol/L and 158.3 nmol/L, respectively. Subgroup analyses revealed lower plasma NO(3)(-) and NO(2)(-) concentrations in individuals with cardiometabolic risk (NO(3)(-): 21.2 μmol/L; 95 % CI, 13.4-29.0; NO(2)(-): 122.8 nmol/L; 95 % CI, 75.3-138.9) compared to healthy (NO(3)(-): 33.9 μmol/L; 95 % CI, 29.9-37.9; NO(2)(-): 159.5 nmol/L; 95 % CI, 131.8-187.1; P < 0.01) and trained individuals (NO(3)(-): 43.0 μmol/L; 95 % CI, 13.2-72.9; NO(2)(-): 199.3 nmol/L; 95 % CI, 117.6-281; P < 0.01). Mean salivary NO(3)(-) and NO(2)(-) concentrations were 546.2 μmol/L and 197.8 μmol/L, respectively. Salivary NO(3)(-), but no NO(2)(-), concentrations were higher in individuals with cardiometabolic risk (680.0 μmol/L; 95 % CI, 510.2-849.8; P = 0.001) compared to healthy individuals (535.9 μmol/L; 95 % CI, 384.2-687.6). A significant positive association (coefficient, 15.4 [95 % CI, 0.255 to 30.5], P = 0.046) was observed between salivary NO(3)(-) and diastolic blood pressure (DBP). These findings suggest that the health status is positively associated with plasma NO(3)(-) and NO(2)(-) concentrations, but the circulatory levels of these anions are not associated with blood pressure. Only salivary NO(3)(-) showed a significant positive association with DBP.
AbstractURLBibTeXEndNoteDOIBibSonomy1.Marina Arroyo M, Ramírez Gallegos I, Paublini H, López-González Ángel A, Tárraga López PJ, Martorell Sánchez C, Sastre-Alzamora T, Ramírez-Manent JI. Usefulness of the Córdoba Equation for Estimating Body Fat When Determining the Level of Risk of Developing Diabetes Type 2 or Prediabetes. Medicina (Kaunas, Lithuania) [Internet]. Switzerland; 2025 Mar.;61(4):613-. https://pubmed.ncbi.nlm.nih.gov/40282904Background and Objectives: Type 2 diabetes (T2D) and prediabetes represent major global health concerns, with obesity being a key risk factor. However, recent evidence suggests that the adipose tissue composition and distribution play a more critical role in metabolic dysfunction than the total body weight or body mass index (BMI). This study evaluates the predictive capacity of the Córdoba Equation for Estimating Body Fat (ECORE-BF) for identifying individuals at high risk of developing T2D and prediabetes. Materials and Methods: A cross-sectional study was carried out involving 418,343 Spanish workers. Body fat percentage was estimated using the ECORE-BF equation, and diabetes risk was assessed using validated predictive models, including the Finnish Diabetes Risk Score (FINDRISC), QDiabetes score (QD-score), and others. The discriminatory power of ECORE-BF in predicting T2D and prediabetes was assessed using receiver operating characteristic (ROC) curve analysis. Results: ECORE-BF showed a strong correlation with high-risk classifications across all diabetes risk scales. The area under the ROC curve (AUC) exceeded 0.95 for both men and women, demonstrating high predictive accuracy. Conclusions: Adipose tissue distribution, particularly visceral adiposity, is a central factor in metabolic dysfunction. ECORE-BF provides a cost-effective alternative for large-scale T2D and prediabetes risk assessment. Future research should explore the impact of visceral adipose tissue reduction on diabetes prevention and the integration of estimation scales into clinical and public health strategies.@article{marinaarroyo2025usefulness,
abstract = {Background and Objectives: Type 2 diabetes (T2D) and prediabetes represent major global health concerns, with obesity being a key risk factor. However, recent evidence suggests that the adipose tissue composition and distribution play a more critical role in metabolic dysfunction than the total body weight or body mass index (BMI). This study evaluates the predictive capacity of the Córdoba Equation for Estimating Body Fat (ECORE-BF) for identifying individuals at high risk of developing T2D and prediabetes. Materials and Methods: A cross-sectional study was carried out involving 418,343 Spanish workers. Body fat percentage was estimated using the ECORE-BF equation, and diabetes risk was assessed using validated predictive models, including the Finnish Diabetes Risk Score (FINDRISC), QDiabetes score (QD-score), and others. The discriminatory power of ECORE-BF in predicting T2D and prediabetes was assessed using receiver operating characteristic (ROC) curve analysis. Results: ECORE-BF showed a strong correlation with high-risk classifications across all diabetes risk scales. The area under the ROC curve (AUC) exceeded 0.95 for both men and women, demonstrating high predictive accuracy. Conclusions: Adipose tissue distribution, particularly visceral adiposity, is a central factor in metabolic dysfunction. ECORE-BF provides a cost-effective alternative for large-scale T2D and prediabetes risk assessment. Future research should explore the impact of visceral adipose tissue reduction on diabetes prevention and the integration of estimation scales into clinical and public health strategies.},
address = {Switzerland},
author = {Marina Arroyo, Marta and Ramírez Gallegos, Ignacio and Paublini, Hernán and López-González, Ángel Arturo and Tárraga López, Pedro J and Martorell Sánchez, Cristina and Sastre-Alzamora, Tomás and Ramírez-Manent, José Ignacio},
journal = {Medicina (Kaunas, Lithuania)},
keywords = {grapp-caib},
month = {mar},
number = 4,
pages = {613--},
title = {Usefulness of the Córdoba Equation for Estimating Body Fat When Determining the Level of Risk of Developing Diabetes Type 2 or Prediabetes},
volume = 61,
year = 2025
}%0 Journal Article
%1 marinaarroyo2025usefulness
%A Marina Arroyo, Marta
%A Ramírez Gallegos, Ignacio
%A Paublini, Hernán
%A López-González, Ángel Arturo
%A Tárraga López, Pedro J
%A Martorell Sánchez, Cristina
%A Sastre-Alzamora, Tomás
%A Ramírez-Manent, José Ignacio
%C Switzerland
%D 2025
%J Medicina (Kaunas, Lithuania)
%N 4
%P 613--
%R 10.3390/medicina61040613
%T Usefulness of the Córdoba Equation for Estimating Body Fat When Determining the Level of Risk of Developing Diabetes Type 2 or Prediabetes
%U https://pubmed.ncbi.nlm.nih.gov/40282904
%V 61
%X Background and Objectives: Type 2 diabetes (T2D) and prediabetes represent major global health concerns, with obesity being a key risk factor. However, recent evidence suggests that the adipose tissue composition and distribution play a more critical role in metabolic dysfunction than the total body weight or body mass index (BMI). This study evaluates the predictive capacity of the Córdoba Equation for Estimating Body Fat (ECORE-BF) for identifying individuals at high risk of developing T2D and prediabetes. Materials and Methods: A cross-sectional study was carried out involving 418,343 Spanish workers. Body fat percentage was estimated using the ECORE-BF equation, and diabetes risk was assessed using validated predictive models, including the Finnish Diabetes Risk Score (FINDRISC), QDiabetes score (QD-score), and others. The discriminatory power of ECORE-BF in predicting T2D and prediabetes was assessed using receiver operating characteristic (ROC) curve analysis. Results: ECORE-BF showed a strong correlation with high-risk classifications across all diabetes risk scales. The area under the ROC curve (AUC) exceeded 0.95 for both men and women, demonstrating high predictive accuracy. Conclusions: Adipose tissue distribution, particularly visceral adiposity, is a central factor in metabolic dysfunction. ECORE-BF provides a cost-effective alternative for large-scale T2D and prediabetes risk assessment. Future research should explore the impact of visceral adipose tissue reduction on diabetes prevention and the integration of estimation scales into clinical and public health strategies.
AbstractURLBibTeXEndNoteDOIBibSonomy1.Obrador de Hevia J, López-González Ángel A, Ramírez-Manent JI, Paublini H, Tárraga López PJ, Martorell Sánchez C, Riutord-Sbert P. Association Between Alcohol Consumption, Other Healthy Habits and Sociodemographic Variables and the Values of Different Insulin Resistance Risk Scales in 139,634 Spanish Workers. Healthcare (Basel, Switzerland) [Internet]. Switzerland; 2025 Apr.;13(8):921-. https://pubmed.ncbi.nlm.nih.gov/40281870Background: Alcohol consumption is a major public health concern, influencing metabolic health and insulin resistance (IR). While moderate alcohol intake has been associated with potential metabolic benefits, excessive consumption is linked to IR and related disorders. This study examines the association between sociodemographic variables, health habits, and IR risk using validated metabolic indices. Methods: A dual-phase study was conducted, including a cross-sectional analysis of 139,634 Spanish workers and a retrospective longitudinal follow-up of 40,431 participants (2009-2019). Data on sociodemographic factors (age, sex and socioeconomic status) and health habits (smoking, alcohol consumption, diet and physical activity) were collected through standardized occupational health assessments. IR risk was assessed using the Triglyceride-Glucose Index (TyG), Metabolic Score for Insulin Resistance (METS-IR), and Single-Point Insulin Sensitivity Estimator (SPISE-IR). Binary logistic regression was used for statistical analysis. Results: Age, male sex, lower socioeconomic status, smoking, alcohol consumption, physical inactivity and low adherence to the Mediterranean diet were significantly associated with higher IR risk across all indices (p < 0.001). Alcohol consumption exhibited a dose-dependent relationship with IR, with excessive intake significantly increasing the risk of IR. Longitudinal data revealed a worsening IR profile over time, particularly among older, low-income and physically inactive individuals. Conclusions: Sociodemographic factors and lifestyle habits strongly influence IR. Preventive strategies focused on reducing alcohol consumption, smoking cessation and promoting physical activity and dietary improvements are essential to mitigate the risk of IR, especially in vulnerable populations. Further longitudinal studies are needed to establish causal relationships and refine intervention strategies.@article{obradordehevia2025association,
abstract = {Background: Alcohol consumption is a major public health concern, influencing metabolic health and insulin resistance (IR). While moderate alcohol intake has been associated with potential metabolic benefits, excessive consumption is linked to IR and related disorders. This study examines the association between sociodemographic variables, health habits, and IR risk using validated metabolic indices. Methods: A dual-phase study was conducted, including a cross-sectional analysis of 139,634 Spanish workers and a retrospective longitudinal follow-up of 40,431 participants (2009-2019). Data on sociodemographic factors (age, sex and socioeconomic status) and health habits (smoking, alcohol consumption, diet and physical activity) were collected through standardized occupational health assessments. IR risk was assessed using the Triglyceride-Glucose Index (TyG), Metabolic Score for Insulin Resistance (METS-IR), and Single-Point Insulin Sensitivity Estimator (SPISE-IR). Binary logistic regression was used for statistical analysis. Results: Age, male sex, lower socioeconomic status, smoking, alcohol consumption, physical inactivity and low adherence to the Mediterranean diet were significantly associated with higher IR risk across all indices (p < 0.001). Alcohol consumption exhibited a dose-dependent relationship with IR, with excessive intake significantly increasing the risk of IR. Longitudinal data revealed a worsening IR profile over time, particularly among older, low-income and physically inactive individuals. Conclusions: Sociodemographic factors and lifestyle habits strongly influence IR. Preventive strategies focused on reducing alcohol consumption, smoking cessation and promoting physical activity and dietary improvements are essential to mitigate the risk of IR, especially in vulnerable populations. Further longitudinal studies are needed to establish causal relationships and refine intervention strategies.},
address = {Switzerland},
author = {Obrador de Hevia, Joan and López-González, Ángel Arturo and Ramírez-Manent, José Ignacio and Paublini, Hernán and Tárraga López, Pedro Juan and Martorell Sánchez, Cristina and Riutord-Sbert, Pere},
journal = {Healthcare (Basel, Switzerland)},
keywords = {grapp-caib},
month = {apr},
number = 8,
pages = {921--},
title = {Association Between Alcohol Consumption, Other Healthy Habits and Sociodemographic Variables and the Values of Different Insulin Resistance Risk Scales in 139,634 Spanish Workers},
volume = 13,
year = 2025
}%0 Journal Article
%1 obradordehevia2025association
%A Obrador de Hevia, Joan
%A López-González, Ángel Arturo
%A Ramírez-Manent, José Ignacio
%A Paublini, Hernán
%A Tárraga López, Pedro Juan
%A Martorell Sánchez, Cristina
%A Riutord-Sbert, Pere
%C Switzerland
%D 2025
%J Healthcare (Basel, Switzerland)
%N 8
%P 921--
%R 10.3390/healthcare13080921
%T Association Between Alcohol Consumption, Other Healthy Habits and Sociodemographic Variables and the Values of Different Insulin Resistance Risk Scales in 139,634 Spanish Workers
%U https://pubmed.ncbi.nlm.nih.gov/40281870
%V 13
%X Background: Alcohol consumption is a major public health concern, influencing metabolic health and insulin resistance (IR). While moderate alcohol intake has been associated with potential metabolic benefits, excessive consumption is linked to IR and related disorders. This study examines the association between sociodemographic variables, health habits, and IR risk using validated metabolic indices. Methods: A dual-phase study was conducted, including a cross-sectional analysis of 139,634 Spanish workers and a retrospective longitudinal follow-up of 40,431 participants (2009-2019). Data on sociodemographic factors (age, sex and socioeconomic status) and health habits (smoking, alcohol consumption, diet and physical activity) were collected through standardized occupational health assessments. IR risk was assessed using the Triglyceride-Glucose Index (TyG), Metabolic Score for Insulin Resistance (METS-IR), and Single-Point Insulin Sensitivity Estimator (SPISE-IR). Binary logistic regression was used for statistical analysis. Results: Age, male sex, lower socioeconomic status, smoking, alcohol consumption, physical inactivity and low adherence to the Mediterranean diet were significantly associated with higher IR risk across all indices (p < 0.001). Alcohol consumption exhibited a dose-dependent relationship with IR, with excessive intake significantly increasing the risk of IR. Longitudinal data revealed a worsening IR profile over time, particularly among older, low-income and physically inactive individuals. Conclusions: Sociodemographic factors and lifestyle habits strongly influence IR. Preventive strategies focused on reducing alcohol consumption, smoking cessation and promoting physical activity and dietary improvements are essential to mitigate the risk of IR, especially in vulnerable populations. Further longitudinal studies are needed to establish causal relationships and refine intervention strategies.
